Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.
about
Advances in the Evaluation of Respiratory Pathophysiology during Exercise in Chronic Lung Diseases.miR-30a as Potential Therapeutics by Targeting TET1 through Regulation of Drp-1 Promoter Hydroxymethylation in Idiopathic Pulmonary Fibrosis.Prognosis and longitudinal changes of physical activity in idiopathic pulmonary fibrosis.A Glimpse into the Future: Automated Quantitative Computed Tomography as a Biomarker in Idiopathic Pulmonary Fibrosis.Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis.Optimizing quality of life in patients with idiopathic pulmonary fibrosis.Idiopathic Pulmonary Fibrosis: The Association between the Adaptive Multiple Features Method and Fibrosis Outcomes.Pulmonary fibrosis, part I: epidemiology, pathogenesis, and diagnosis.Clarity on Endpoints for Clinical Trials in Idiopathic Pulmonary Fibrosis.Co-morbidity and mortality among patients with interstitial lung diseases: A population-based study.Extracellular Mitochondrial DNA Is Generated by Fibroblasts and Predicts Death in Idiopathic Pulmonary Fibrosis.Acute Exacerbation and Decline in Forced Vital Capacity Are Associated with Increased Mortality in Idiopathic Pulmonary Fibrosis.Update in Interstitial Lung Disease 2016.Clinical Trial Design Based on Time to Death/Progression.Prognosis and Follow-Up of Idiopathic Pulmonary Fibrosis.Investigating the effects of nintedanib on biomarkers of extracellular matrix turnover in patients with IPF: design of the randomised placebo-controlled INMARK®trial
P2860
Q37656969-E09ADD24-3444-409B-9128-761B6585D5FFQ37729301-F96D79CB-C6E8-4489-92CC-0A7033755590Q38661833-61D0CE9B-2840-4989-89A1-1AA8D49EE712Q38737267-A512F730-7EFE-4055-B250-28439947CA0BQ38804833-99FFDCDD-CF80-432E-A8BB-D33392D28419Q39108878-73A21DFA-3CDE-4E7B-B859-ED80F66EC021Q39262934-CD9C5D34-7A22-4858-B8B5-8C7EB7978EF6Q40272697-4BE2356A-CBC9-40BC-9A63-048DD7A2F363Q46863202-A38E2DE9-C5ED-4471-ADC8-E3B3F3D2D8F2Q47678274-B8C2778C-64D1-45C0-8322-8DF2C9A31283Q47699997-CE652380-3E44-4941-8232-90638BC95C04Q48304185-3D9BD79B-D745-44E3-9DCD-B0C533D93069Q49734357-71A172F3-4568-4076-B109-20BEAA29433CQ51810369-433950B4-969D-4FCF-A36E-EF7DD3131804Q55414885-A768487E-F7A3-482E-A209-4888893CDAE7Q58735224-A9B36DD6-E5F0-498E-8322-78AD48EAD6C3
P2860
Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@en
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@nl
type
label
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@en
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@nl
prefLabel
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@en
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@nl
P2093
P2860
P1476
Predictors of Mortality Poorly ...... Idiopathic Pulmonary Fibrosis.
@en
P2093
Derek Weycker
Eric Vittinghoff
Harold R Collard
Roland M du Bois
Williamson Z Bradford
P2860
P304
P356
10.1164/RCCM.201508-1546OC
P407
P577
2016-03-03T00:00:00Z